Skip to main content

Management of Choroidal Hemangioma

  • Chapter
  • First Online:
Ocular Oncology

Part of the book series: Current Practices in Ophthalmology ((CUPROP))

  • 365 Accesses

Abstract

Choroidal hemangioma, a benign vascular tumor, exists in two clinically distinct forms as either a circumscribed or a diffuse lesion and typically involves the posterior pole. Most patients present with decreased visual acuity secondary to subretinal fluid (SRF). In addition to exam, optical coherence tomography (OCT), ultrasonography, fluorescein (FA) and indocyanine green (ICGA) angiography, and magnetic resonance imaging (MRI) all play a role in the diagnosis of choroidal hemangioma. This chapter explores various approaches to therapy, both historical and current, used to treat this choroidal tumor and secondary exudative retinal detachment (ERD). Treatment modalities include laser photocoagulation, transpupillary thermotherapy, photodynamic therapy (PDT), intravitreal anti-VEGF or steroid injection, systemic beta-blockers, plaque brachytherapy, proton beam irradiation, external beam radiotherapy, and gamma knife irradiation. There are many considerations to treatment which include size of the tumor, presence or absence of exudative retinal detachment, prior treatment failures, patient’s ability to undergo surgery, and other comorbidities. Time between onset of symptoms and treatment has been shown to affect visual prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

CCH:

Circumscribed choroidal hemangioma

CME:

Cystoid macular edema

CNV:

Choroidal neovascularization

DCH:

Diffuse choroidal hemangioma

ERD:

Exudative retinal detachment

FA:

Fluorescein angiography

ICG-A:

Indocyanine green angiography

IVB:

Intravitreal bevacizumab

IVT:

Intravitreal triamcinolone

LSRT:

Lens-sparing radiotherapy

MRI:

Magnetic resonance imaging

NVD:

Neovascularization of the disc

NVE:

Retinal neovascularization elsewhere

OCT:

Optical coherence tomography

OCT-A:

Optical coherence tomography angiography

PDT:

Photodynamic therapy

RPE:

Retinal pigment epithelium

SRF:

Subretinal fluid

SWS:

Sturge-Weber syndrome

TTT:

Transpupillary thermotherapy

VEGF:

Vascular endothelial growth factor

References

  1. Witschel H, Font RL. Hemangioma of the choroid. A clinicopathologic study of 71 cases and a review of the literature. Surv Ophthalmol. 1976;20(6):415–31.

    Article  CAS  Google Scholar 

  2. Mashayekhi A, Shields CL. Circumscribed choroidal hemangioma. Curr Opin Ophthalmol. 2003;14(3):142–9.

    Article  Google Scholar 

  3. Shields CL, Honavar SG, Shields JA, Cater J, Demirci H. Circumscribed choroidal hemangioma: clinical manifestations and factors predictive of visual outcome in 200 consecutive cases. Ophthalmology. 2001;108(12):2237–48.

    Article  CAS  Google Scholar 

  4. Koenraads Y, van Egmond-Ebbeling MB, de Boer JH, Imhof SM, Braun KP, Porro GL. Visual outcome in Sturge-Weber syndrome: a systematic review and Dutch multicentre cohort. Acta Ophthalmol. 2016;94(7):638–45. https://doi.org/10.1111/aos.13074.

    Article  PubMed  Google Scholar 

  5. Cheung D, Grey R, Rennie I. Circumscribed choroidal haemangioma in a patient with Sturge Weber syndrome. Eye (Lond). 2000;14(Pt 2):238–40. https://doi.org/10.1038/eye.2000.61.

    Article  Google Scholar 

  6. Jarrett WH 2nd, Hagler WS, Larose JH, Shields JA. Clinical experience with presumed hemangioma of the choroid: radioactive phosphorus uptake studies as an aid in differential diagnosis. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1976;81(5):862–70.

    PubMed  Google Scholar 

  7. Hsu CC, Yang CS, Peng CH, Lee FL, Lee SM. Combination photodynamic therapy and intravitreal bevacizumab used to treat circumscribed choroidal hemangioma. J Chin Med Assoc. 2011;74(10):473–7. https://doi.org/10.1016/j.jcma.2011.08.020.

    Article  PubMed  Google Scholar 

  8. Shields JA, Shields CL. Intraocular tumors: an atlas and textbook. 2nd ed. Baltimore: Lippincott Williams & Wilkins; 2008.

    Google Scholar 

  9. Leys AM, Silva R, Inhoffen W, Tatar O. Neovascular growth following photodynamic therapy for choroidal hemangioma and neovascular regression after intravitreous injection of triamcinolone. Retina. 2006;26(6):693–7. https://doi.org/10.1097/01.iae.0000236482.40056.fe.

    Article  PubMed  Google Scholar 

  10. Hua R, Zhao N, Hu Y, Zhang CM, Chen L. Circumscribed choroidal hemangioma associated with choroidal neovascularization in a HIV-infected case: photodynamic therapy and intravitreous ranibizumab. Photodiagn Photodyn Ther. 2014;11(3):441–3. https://doi.org/10.1016/j.pdpdt.2014.04.005.

    Article  CAS  Google Scholar 

  11. Scott IU, Alexandrakis G, Cordahi GJ, Murray TG. Diffuse and circumscribed choroidal hemangiomas in a patient with Sturge-Weber syndrome. Arch Ophthalmol. 1999;117(3):406–7.

    CAS  PubMed  Google Scholar 

  12. Shields CL, Atalay HT, Wuthisiri W, Levin AV, Lally SE, Shields JA. Sector iris hemangioma in association with diffuse choroidal hemangioma. J AAPOS. 2015;19(1):83–6. https://doi.org/10.1016/j.jaapos.2014.09.012.

    Article  PubMed  Google Scholar 

  13. Plateroti AM, Plateroti R, Mollo R, Librando A, Contestabile MT, Fenicia V. Sturge-weber syndrome associated with monolateral ocular melanocytosis, Iris mammillations, and diffuse choroidal haemangioma. Case Rep Ophthalmol. 2017;8(2):375–84. https://doi.org/10.1159/000477612.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Tanabe H, Sahashi K, Kitano T, Tomita Y, Saito AM, Hirose H. Effects of oral propranolol on circumscribed choroidal hemangioma: a pilot study. JAMA Ophthalmol. 2013;131(12):1617–22. https://doi.org/10.1001/jamaophthalmol.2013.5669.

    Article  PubMed  Google Scholar 

  15. Medlock RD, Augsburger JJ, Wilkinson CP, Cox MS Jr, Gamel JW, Nicholl J. Enlargement of circumscribed choroidal hemangiomas. Retina. 1991;11(4):385–8.

    Article  CAS  Google Scholar 

  16. Kwon HJ, Kim M, Lee CS, Lee SC. Treatment of serous macular detachment associated with circumscribed choroidal hemangioma. Am J Ophthalmol. 2012;154(1):137–145.e131. https://doi.org/10.1016/j.ajo.2012.01.007.

    Article  PubMed  Google Scholar 

  17. Schalenbourg A, Piguet B, Zografos L. Indocyanine green angiographic findings in choroidal hemangiomas: a study of 75 cases. Ophthalmologica. 2000;214(4):246–52. https://doi.org/10.1159/000027499.

    Article  CAS  PubMed  Google Scholar 

  18. Norton EW, Gutman F. Fluorescein angiography and hemangiomas of the choroid. Arch Ophthalmol. 1967;78(2):121–5.

    Article  CAS  Google Scholar 

  19. Anand R. Photodynamic therapy for diffuse choroidal hemangioma associated with Sturge Weber syndrome. Am J Ophthalmol. 2003;136(4):758–60.

    Article  Google Scholar 

  20. Arevalo JF, Shields CL, Shields JA, Hykin PG, De Potter P. Circumscribed choroidal hemangioma: characteristic features with indocyanine green videoangiography. Ophthalmology. 2000;107(2):344–50.

    Article  CAS  Google Scholar 

  21. Singh AD, Kaiser PK, Sears JE. Choroidal hemangioma. Ophthalmol Clin N Am. 2005;18(1):151–161, ix. https://doi.org/10.1016/j.ohc.2004.07.004.

    Article  Google Scholar 

  22. Krema H, Yousef YA, Durairaj P, Santiago R. Failure of systemic propranolol therapy for choroidal hemangioma of Sturge-Weber syndrome: a report of 2 cases. JAMA Ophthalmol. 2013;131(5):681–3. https://doi.org/10.1001/jamaophthalmol.2013.2879.

    Article  PubMed  Google Scholar 

  23. Arevalo JF, Arias JD, Serrano MA. Oral propranolol for exudative retinal detachment in diffuse choroidal hemangioma. Arch Ophthalmol. 2011;129(10):1373–5. https://doi.org/10.1001/archophthalmol.2011.294.

    Article  PubMed  Google Scholar 

  24. Cennamo G, Romano MR, Breve MA, Velotti N, Reibaldi M, de Crecchio G, Cennamo G. Evaluation of choroidal tumors with optical coherence tomography: enhanced depth imaging and OCT-angiography features. Eye (Lond). 2017;31(6):906–15. https://doi.org/10.1038/eye.2017.14.

    Article  CAS  Google Scholar 

  25. Torres VL, Brugnoni N, Kaiser PK, Singh AD. Optical coherence tomography enhanced depth imaging of choroidal tumors. Am J Ophthalmol. 2011;151(4):586–593.e582. https://doi.org/10.1016/j.ajo.2010.09.028.

    Article  PubMed  Google Scholar 

  26. Shields CL, Manalac J, Das C, Saktanasate J, Shields JA. Review of spectral domain enhanced depth imaging optical coherence tomography of tumors of the choroid. Indian J Ophthalmol. 2015;63(2):117–21. https://doi.org/10.4103/0301-4738.154377.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Stroszczynski C, Hosten N, Bornfeld N, Wiegel T, Schueler A, Foerster P, Lemke AJ, Hoffmann KT, Felix R. Choroidal hemangioma: MR findings and differentiation from uveal melanoma. Am J Neuroradiol. 1998;19(8):1441–7.

    CAS  PubMed  Google Scholar 

  28. Peyster RG, Augsburger JJ, Shields JA, Hershey BL, Eagle R Jr, Haskin ME. Intraocular tumors: evaluation with MR imaging. Radiology. 1988;168(3):773–9. https://doi.org/10.1148/radiology.168.3.3406407.

    Article  CAS  PubMed  Google Scholar 

  29. Damento GM, Koeller KK, Salomao DR, Pulido JS. T2 fluid-attenuated inversion recovery imaging of uveal melanomas and other ocular pathology. Ocular Oncol Pathol. 2016;2(4):251–61. https://doi.org/10.1159/000447265.

    Article  Google Scholar 

  30. Ramasubramanian A, Shields CL, Harmon SA, Shields JA. Autofluorescence of choroidal hemangioma in 34 consecutive eyes. Retina. 2010;30(1):16–22. https://doi.org/10.1097/IAE.0b013e3181bceedb.

    Article  PubMed  Google Scholar 

  31. Anand R, Augsburger JJ, Shields JA. Circumscribed choroidal hemangiomas. Arch Ophthalmol. 1989;107(9):1338–42.

    Article  CAS  Google Scholar 

  32. Tsipursky MS, Golchet PR, Jampol LM. Photodynamic therapy of choroidal hemangioma in Sturge-Weber syndrome, with a review of treatments for diffuse and circumscribed choroidal hemangiomas. Surv Ophthalmol. 2011;56(1):68–85. https://doi.org/10.1016/j.survophthal.2010.08.002.

    Article  PubMed  Google Scholar 

  33. Karimi S, Nourinia R, Mashayekhi A. Circumscribed choroidal hemangioma. J Ophthalmic Vis Res. 2015;10(3):320–8. https://doi.org/10.4103/2008-322x.170353.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Yim JF, Sandinha T, Kerr JM, Ritchie D, Kemp EG. Treatment review of sight threatening circumscribed choroidal haemangioma. Int J Ophthalmol. 2010;3(2):168–71. https://doi.org/10.3980/j.issn.2222-3959.2010.02.18.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Cennamo G, Breve MA, Rossi C, Romano MR, de Crecchio G, Cennamo G. Transpupillary thermotherapy as a primary treatment for circumscribed choroidal haemangioma. Acta Ophthalmol. 2016;94(2):e167–9. https://doi.org/10.1111/aos.12810.

    Article  PubMed  Google Scholar 

  36. Gambrelle J, Kivela T, Grange JD. Sturge-Weber syndrome: decrease in intraocular pressure after transpupillary thermotherapy for diffuse choroidal haemangioma. Acta Ophthalmol. 2011;89(2):190–3. https://doi.org/10.1111/j.1755-3768.2009.01811.x.

    Article  PubMed  Google Scholar 

  37. Newman DK. Photodynamic therapy: current role in the treatment of chorioretinal conditions. Eye (Lond). 2016;30(2):202–10. https://doi.org/10.1038/eye.2015.251.

    Article  CAS  Google Scholar 

  38. Schmidt-Erfurth UM, Michels S, Kusserow C, Jurklies B, Augustin AJ. Photodynamic therapy for symptomatic choroidal hemangioma: visual and anatomic results. Ophthalmology. 2002;109(12):2284–94.

    Article  Google Scholar 

  39. Chan WM, Lim TH, Pece A, Silva R, Yoshimura N. Verteporfin PDT for non-standard indications—a review of current literature. Graefe’s Arch Clin Exp Ophthalmol. 2010;248(5):613–26. https://doi.org/10.1007/s00417-010-1307-z.

    Article  CAS  Google Scholar 

  40. Pilotto E, Urban F, Parrozzani R, Midena E. Standard versus bolus photodynamic therapy in circumscribed choroidal hemangioma: functional outcomes. Eur J Ophthalmol. 2011;21(4):452–8. https://doi.org/10.5301/ejo.2011.6263.

    Article  PubMed  Google Scholar 

  41. Su ZA, Tang XJ, Zhang LX, Su XH. Comparison of outcomes between overlapping-spot and single-spot photodynamic therapy for circumscribed choroidal hemangioma. Int J Ophthalmol. 2014;7(1):66–70. https://doi.org/10.3980/j.issn.2222-3959.2014.01.12.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Blasi MA, Tiberti AC, Scupola A, Balestrazzi A, Colangelo E, Valente P, Balestrazzi E. Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes. Ophthalmology. 2010;117(8):1630–7. https://doi.org/10.1016/j.ophtha.2009.12.033.

    Article  PubMed  Google Scholar 

  43. Hu Y, Chen Y, Chen L. Half-dosage and bolus injection photodynamic therapy for symptomatic circumscribed choroidal hemangioma: a case report. Photodiagn Photodyn Ther. 2015;12(3):526–9. https://doi.org/10.1016/j.pdpdt.2015.05.005.

    Article  Google Scholar 

  44. Subira O, Brosa H, Lorenzo-Parra D, Arias-Barquet L, Catala-Mora J, Cobos E, Garcia-Bru P, Rubio-Caso MJ, Caminal-Mitjana JM. Choroidal haemangioma and photodynamic therapy. Anatomical and functional response of patients with choroidal hemangioma treated with photodynamic therapy. Arch Soc Esp Oftalmol. 2017;92(6):257–64. https://doi.org/10.1016/j.oftal.2016.11.013.

    Article  CAS  PubMed  Google Scholar 

  45. Huang S, Fabian J, Murray T, Shi W. Symptomatic circumscribed choroidal hemangioma undergoing PDT: VA outcomes. Optom Vis Sci. 2009;86(3):286–9. https://doi.org/10.1097/OPX.0b013e318196a724.

    Article  PubMed  Google Scholar 

  46. Xiong Y, Zhang F. Photodynamic therapy for circumscribed choroidal hemangioma. Zhonghua Yan Ke Za Zhi. 2007;43(12):1085–8.

    PubMed  Google Scholar 

  47. Guagnini AP, De Potter P, Levecq L. Photodynamic therapy of circumscribed choroidal hemangiomas. J Fr Ophtalmol. 2006;29(9):1013–7.

    Article  Google Scholar 

  48. Landau IM, Steen B, Seregard S. Photodynamic therapy for circumscribed choroidal haemangioma. Acta Ophthalmol Scand. 2002;80(5):531–6.

    Article  Google Scholar 

  49. Hussain RN, Jmor F, Damato B, Heimann H. Verteporfin photodynamic therapy for the treatment of choroidal haemangioma associated with Sturge-Weber syndrome. Photodiagn Photodyn Ther. 2016;15:143–6. https://doi.org/10.1016/j.pdpdt.2016.06.009.

    Article  CAS  Google Scholar 

  50. Nugent R, Lee L, Kwan A. Photodynamic therapy for diffuse choroidal hemangioma in a child with Sturge-Weber syndrome. J AAPOS. 2015;19(2):181–3. https://doi.org/10.1016/j.jaapos.2014.10.032.

    Article  PubMed  Google Scholar 

  51. Poh KW, Wai YZ, Rahmat J, Shunmugam M, Alagaratnam J, Ramasamy S. Treatment of diffuse choroidal haemangioma using photodynamic therapy. Int J Ophthalmol. 2017;10(3):488–90. https://doi.org/10.18240/ijo.2017.03.26.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Huiskamp EA, Muskens RP, Ballast A, Hooymans JM. Diffuse choroidal haemangioma in Sturge-Weber syndrome treated with photodynamic therapy under general anaesthesia. Graefe’s Arch Clin Exp Ophthalmol. 2005;243(7):727–30. https://doi.org/10.1007/s00417-004-1102-9.

    Article  CAS  Google Scholar 

  53. Cacciamani A, Scarinci F, Parravano M, Giorno P, Varano M. Choroidal thickness changes with photodynamic therapy for a diffuse choroidal hemangioma in Sturge-Weber syndrome. Int Ophthalmol. 2014;34(5):1131–5. https://doi.org/10.1007/s10792-014-9933-9.

    Article  PubMed  Google Scholar 

  54. Li KZ, Tan CS. Changes in choroidal thickness after photodynamic therapy for Sturge-Weber syndrome. Int Ophthalmol. 2015;35(5):615–6. https://doi.org/10.1007/s10792-015-0077-3.

    Article  PubMed  Google Scholar 

  55. Nagesha CK, Walinjkar JA, Khetan V. Choroidal neovascular membrane in a treated choroidal hemangioma. Indian J Ophthalmol. 2016;64(8):606–8. https://doi.org/10.4103/0301-4738.191512.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Mandal S, Naithani P, Venkatesh P, Garg S. Intravitreal bevacizumab (avastin) for circumscribed choroidal hemangioma. Indian J Ophthalmol. 2011;59(3):248–51. https://doi.org/10.4103/0301-4738.81051.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Sagong M, Lee J, Chang W. Application of intravitreal bevacizumab for circumscribed choroidal hemangioma. Korean J Ophthalmol: KJO. 2009;23(2):127–31. https://doi.org/10.3341/kjo.2009.23.2.127.

    Article  PubMed  Google Scholar 

  58. Anaya-Pava EJ, Saenz-Bocanegra CH, Flores-Trejo A, Castro-Santana NA. Diffuse choroidal hemangioma associated with exudative retinal detachment in a Sturge-Weber syndrome case: photodynamic therapy and intravitreous bevacizumab. Photodiagn Photodyn Ther. 2015;12(1):136–9. https://doi.org/10.1016/j.pdpdt.2014.12.002.

    Article  Google Scholar 

  59. Chan LW, Hsieh YT. Photodynamic therapy for choroidal hemangioma unresponsive to ranibizumab. Optom Vis Sci. 2014;91(9):e226–9. https://doi.org/10.1097/opx.0000000000000349.

    Article  PubMed  Google Scholar 

  60. Querques G, Forte R, Querques L, Souied EH. Intravitreal ranibizumab for choroidal neovascularization associated with circumscribed choroidal haemangioma. Clin Exp Ophthalmol. 2011;39(9):916–8. https://doi.org/10.1111/j.1442-9071.2011.02580.x.

    Article  PubMed  Google Scholar 

  61. Bach A, Gold AS, Villegas VM, Wildner AC, Ehlies FJ, Murray TG. Spontaneous exudative retinal detachment in a patient with Sturge-Weber syndrome after taking arginine, a supplement for erectile dysfunction. Eye Vis. 2014;1:7. https://doi.org/10.1186/s40662-014-0007-x.

    Article  Google Scholar 

  62. Paulus YM, Jain A, Moshfeghi DM. Resolution of persistent exudative retinal detachment in a case of Sturge-Weber syndrome with anti-VEGF administration. Ocul Immunol Inflamm. 2009;17(4):292–4. https://doi.org/10.1080/09273940902989357.

    Article  PubMed  Google Scholar 

  63. Sommers Smith SK, Smith DM. Beta blockade induces apoptosis in cultured capillary endothelial cells. In Vitro Cell Dev Biol Anim. 2002;38(5):298–304. https://doi.org/10.1290/1071-2690(2002)038<0298:bbiaic>2.0.co;2.

    Article  CAS  PubMed  Google Scholar 

  64. Giatromanolaki A, Arvanitidou V, Hatzimichael A, Simopoulos C, Sivridis E. The HIF-2alpha/VEGF pathway activation in cutaneous capillary haemangiomas. Pathology. 2005;37(2):149–51.

    Article  CAS  Google Scholar 

  65. Sanz-Marco E, Gallego R, Diaz-Llopis M. Oral propranolol for circumscribed choroidal hemangioma. Case Rep Ophthalmol. 2011;2(1):84–90. https://doi.org/10.1159/000325142.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649–51. https://doi.org/10.1056/NEJMc0708819.

    Article  CAS  PubMed  Google Scholar 

  67. Thapa R, Shields CL. Oral propranolol therapy for management of exudative retinal detachment from diffuse choroidal hemangioma in Sturge-Weber syndrome. Eur J Ophthalmol. 2013;23(6):922–4. https://doi.org/10.5301/ejo.5000322.

    Article  PubMed  Google Scholar 

  68. Bazin L, Gambrelle J. Combined treatment with photodynamic therapy and intravitreal dexamethasone implant (Ozurdex((R))) for circumscribed choroidal hemangioma. J Fr Ophtalmol. 2012;35(10):798–802. https://doi.org/10.1016/j.jfo.2012.06.015.

    Article  CAS  PubMed  Google Scholar 

  69. Quagliano F, Fontana L, Parente G, Tassinari G. Choroidal effusion after diode laser cyclophotocoagulation in Sturge-Weber syndrome. J AAPOS. 2008;12(5):526–7. https://doi.org/10.1016/j.jaapos.2008.03.014.

    Article  PubMed  Google Scholar 

  70. Lopez-Caballero C, Saornil MA, De Frutos J, Bianciotto C, Muinos Y, Almaraz A, Lopez-Lara F, Contreras I. High-dose iodine-125 episcleral brachytherapy for circumscribed choroidal haemangioma. Br J Ophthalmol. 2010;94(4):470–3. https://doi.org/10.1136/bjo.2009.160184.

    Article  CAS  PubMed  Google Scholar 

  71. Zografos L, Bercher L, Chamot L, Gailloud C, Raimondi S, Egger E. Cobalt-60 treatment of choroidal hemangiomas. Am J Ophthalmol. 1996;121(2):190–9.

    Article  CAS  Google Scholar 

  72. Madreperla SA, Hungerford JL, Plowman PN, Laganowski HC, Gregory PT. Choroidal hemangiomas: visual and anatomic results of treatment by photocoagulation or radiation therapy. Ophthalmology. 1997;104(11):1773–8; discussion 1779.

    Article  CAS  Google Scholar 

  73. Aizman A, Finger PT, Shabto U, Szechter A, Berson A. Palladium 103 (103Pd) plaque radiation therapy for circumscribed choroidal hemangioma with retinal detachment. Arch Ophthalmol. 2004;122(11):1652–6. https://doi.org/10.1001/archopht.122.11.1652.

    Article  PubMed  Google Scholar 

  74. Kubicka-Trzaska A, Karska-Basta I, Oleksy P, Romanowska-Dixon B. Management of diffuse choroidal hemangioma in Sturge-Weber syndrome with Ruthenium-106 plaque radiotherapy. Graefe’s Arch Clin Exp Ophthalmol. 2015;253(11):2015–9. https://doi.org/10.1007/s00417-015-3061-8.

    Article  Google Scholar 

  75. Frau E, Rumen F, Noel G, Delacroix S, Habrand JL, Offret H. Low-dose proton beam therapy for circumscribed choroidal hemangiomas. Arch Ophthalmol. 2004;122(10):1471–5. https://doi.org/10.1001/archopht.122.10.1471.

    Article  PubMed  Google Scholar 

  76. Levy-Gabriel C, Rouic LL, Plancher C, Dendale R, Delacroix S, Asselain B, Habrand JL, Desjardins L. Long-term results of low-dose proton beam therapy for circumscribed choroidal hemangiomas. Retina. 2009;29(2):170–5. https://doi.org/10.1097/IAE.0b013e31818bccfb.

    Article  PubMed  Google Scholar 

  77. Chan RV, Yonekawa Y, Lane AM, Skondra D, Munzenrider JE, Collier JM, Gragoudas ES, Kim IK. Proton beam irradiation using a light-field technique for the treatment of choroidal hemangiomas. Ophthalmologica. 2010;224(4):209–16. https://doi.org/10.1159/000260226.

    Article  PubMed  Google Scholar 

  78. Schilling H, Sauerwein W, Lommatzsch A, Friedrichs W, Brylak S, Bornfeld N, Wessing A. Long-term results after low dose ocular irradiation for choroidal haemangiomas. Br J Ophthalmol. 1997;81(4):267–73.

    Article  CAS  Google Scholar 

  79. Ritland JS, Eide N, Tausjo J. External beam irradiation therapy for choroidal haemangiomas. Visual and anatomical results after a dose of 20 to 25 Gy. Acta Ophthalmol Scand. 2001;79(2):184–6.

    Article  CAS  Google Scholar 

  80. Kim YT, Kang SW, Lee JI. Gamma knife radiosurgery for choroidal hemangioma. Int J Radiat Oncol Biol Phys. 2011;81(5):1399–404. https://doi.org/10.1016/j.ijrobp.2010.08.016.

    Article  PubMed  Google Scholar 

  81. Song WK, Byeon SH, Kim SS, Kwon OW, Lee SC. Gamma knife radiosurgery for choroidal haemangiomas with extensive exudative retinal detachment. Br J Ophthalmol. 2009;93(6):836–7. https://doi.org/10.1136/bjo.2008.151316.

    Article  CAS  PubMed  Google Scholar 

  82. Boixadera A, Garcia-Arumi J, Martinez-Castillo V, Encinas JL, Elizalde J, Blanco-Mateos G, Caminal J, Capeans C, Armada F, Navea A, Olea JL. Prospective clinical trial evaluating the efficacy of photodynamic therapy for symptomatic circumscribed choroidal hemangioma. Ophthalmology. 2009;116(1):100–105.e101. https://doi.org/10.1016/j.ophtha.2008.08.029.

    Article  PubMed  Google Scholar 

  83. Jurklies B, Anastassiou G, Ortmans S, Schuler A, Schilling H, Schmidt-Erfurth U, Bornfeld N. Photodynamic therapy using verteporfin in circumscribed choroidal haemangioma. Br J Ophthalmol. 2003;87(1):84–9.

    Article  CAS  Google Scholar 

  84. Michels S, Michels R, Simader C, Schmidt-Erfurth U. Verteporfin therapy for choroidal hemangioma: a long-term follow-up. Retina. 2005;25(6):697–703.

    Article  Google Scholar 

  85. Verbraak FD, Schlingemann RO, Keunen JE, de Smet MD. Longstanding symptomatic choroidal hemangioma managed with limited PDT as initial or salvage therapy. Graefe’s Arch Clin Exp Ophthalmol. 2003;241(11):891–8. https://doi.org/10.1007/s00417-003-0765-y.

    Article  CAS  Google Scholar 

  86. Singh AD, Kaiser PK, Sears JE, Gupta M, Rundle PA, Rennie IG. Photodynamic therapy of circumscribed choroidal haemangioma. Br J Ophthalmol. 2004;88(11):1414–8. https://doi.org/10.1136/bjo.2004.044396.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Porrini G, Giovannini A, Amato G, Ioni A, Pantanetti M. Photodynamic therapy of circumscribed choroidal hemangioma. Ophthalmology. 2003;110(4):674–80. https://doi.org/10.1016/s0161-6420(02)01968-1.

    Article  PubMed  Google Scholar 

  88. Dave T, Dave VP, Shah G, Pappuru RR. Diffuse choroidal hemangioma masquerading as central serous chorioretinopathy treated with oral propranolol. Retin Cases Brief Rep. 2016;10(1):11–4. https://doi.org/10.1097/icb.0000000000000165.

    Article  CAS  PubMed  Google Scholar 

  89. Kaushik S, Kaur S, Pandav SS, Gupta A. Intractable choroidal effusion with exudative retinal detachment in Sturge-Weber syndrome. JAMA Ophthalmol. 2014;132(9):1143–4. https://doi.org/10.1001/jamaophthalmol.2014.2464.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Denis Jusufbegovic .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Aebi, B.E., Jusufbegovic, D. (2019). Management of Choroidal Hemangioma. In: Ramasubramanian, A. (eds) Ocular Oncology . Current Practices in Ophthalmology. Springer, Singapore. https://doi.org/10.1007/978-981-13-7538-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-7538-5_8

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-7537-8

  • Online ISBN: 978-981-13-7538-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics